Summarized by Masters of Longevity from TechCrunch.
Report on a major AI lab acquiring a small biotech software team to integrate operational AI agents into its life sciences research platform and workbench.
Key Takeaways
- Close TechCrunch Desktop Logo TechCrunch Mobile Logo OpenAI acquires startup Orchestra Bio to beef up its biotech business OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced via its website.
- Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC.
- OpenAI has already won some big names as customers for Rosalind, including, it says, Moderna and Novo Nordisk.
